Harmony Biosciences (HRMY) News Today $34.28 +0.39 (+1.15%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period What is HC Wainwright's Estimate for HRMY FY2024 Earnings?December 21 at 1:11 AM | americanbankingnews.comFY2024 Earnings Estimate for HRMY Issued By HC WainwrightHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Equities researchers at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a note issued to investors on Tuesday, December 17th. HC Wainwright analyst P. Trucchio anticipates that the comDecember 20 at 6:21 AM | marketbeat.comState Street Corp Decreases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)State Street Corp reduced its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 2.6% during the third quarter, according to its most recent filing with the SEC. The fund owned 1,240,598 shares of the company's stock after selling 32,900 shares during the quarter. State StreDecember 20 at 3:39 AM | marketbeat.comHARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEDecember 18 at 8:05 AM | prnewswire.comHarmony Biosciences Set for Growth with WAKIX Expansion and Promising Neurology Pipeline, Says Analyst Patrick TrucchioDecember 18 at 4:24 AM | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy RecommendationDecember 17, 2024 | msn.comHarmony Biosciences (NASDAQ:HRMY) Stock Price Up 3.6% - What's Next?Harmony Biosciences (NASDAQ:HRMY) Stock Price Up 3.6% - Here's What HappenedDecember 17, 2024 | marketbeat.comShort Interest in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Declines By 6.0%Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 5,450,000 shares, a drop of 6.0% from the November 15th total of 5,800,000 shares. Based on an average trading volume of 750,400 shares, the days-to-cover ratio is currently 7.3 days. Currently, 13.5% of the shares of the stock are sold short.December 17, 2024 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright initiated coverage on shares of Harmony Biosciences in a report on Tuesday. They set a "buy" rating and a $75.00 target price on the stock.December 17, 2024 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by HighTower Advisors LLCHighTower Advisors LLC increased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 364.0% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 79,961 shares of the company's stock after purDecember 13, 2024 | marketbeat.comHarmony Biosciences to Join Fireside Chat at Oppenheimer Rare Disease SummitDecember 9, 2024 | msn.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stake Reduced by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. reduced its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 8.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 224,481 shares of tDecember 6, 2024 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Verition Fund Management LLCVerition Fund Management LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 168.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 54,976 shares of the company's stocDecember 6, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Merus (MRUS), IQVIA Holdings (IQV) and Harmony Biosciences Holdings (HRMY)December 5, 2024 | markets.businessinsider.comHARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMITDecember 3, 2024 | prnewswire.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and seven haveDecember 3, 2024 | marketbeat.comMartingale Asset Management L P Buys 14,946 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Martingale Asset Management L P grew its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 75.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,783 shares of the compDecember 2, 2024 | marketbeat.comCitigroup Inc. Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Citigroup Inc. grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 9.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 177,843 shares of tDecember 1, 2024 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Stock Price Down 3.1% - Here's What HappenedHarmony Biosciences (NASDAQ:HRMY) Trading Down 3.1% - Here's WhyNovember 29, 2024 | marketbeat.comHarmony Biosciences Hits the Stage: Engaging Investors at Top 2024 ConferencesNovember 26, 2024 | msn.comMassachusetts Financial Services Co. MA Grows Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Massachusetts Financial Services Co. MA boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 27.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 660,391 shares of the company's stock aNovember 26, 2024 | marketbeat.com18,882 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Acquired by StoneX Group Inc.StoneX Group Inc. bought a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 18,882 shares of the company's stock, valuNovember 25, 2024 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. cut its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 18.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 68,998 shares of the company's stock after sellingNovember 24, 2024 | marketbeat.comPacer Advisors Inc. Decreases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Pacer Advisors Inc. decreased its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 23.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,928,336 shares of the company's stock after sellingNovember 22, 2024 | marketbeat.comHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESNovember 21, 2024 | prnewswire.comQuest Partners LLC Acquires 20,689 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Quest Partners LLC boosted its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 137.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 35,723 shares of the company's stock after purchasingNovember 20, 2024 | marketbeat.comPrincipal Financial Group Inc. Sells 19,654 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Principal Financial Group Inc. decreased its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 10.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 162,469 sharesNovember 20, 2024 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Down 18.7% in OctoberHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 6,060,000 shares, a decline of 18.7% from the October 15th total of 7,450,000 shares. Approximately 15.2% of the company's stock are short sold. Based on an average daily volume of 683,700 shares, the short-interest ratio is currently 8.9 days.November 17, 2024 | marketbeat.comCWA Asset Management Group LLC Purchases New Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)CWA Asset Management Group LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 14,396 shares of the company's stock, valued at approximately $576,000. OtherNovember 12, 2024 | marketbeat.comHarmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection PointsNovember 11, 2024 | seekingalpha.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from AnalystsShares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have earned a consensus rating of "Moderate Buy" from the nine ratings firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and seven haveNovember 8, 2024 | marketbeat.comHarmony Biosciences Holdings: Strong Growth Potential and Attractive Valuation Amidst Robust Product PipelineNovember 5, 2024 | markets.businessinsider.comHarmony Biosciences Reports Record Revenue and Plans Expansion in CNS TreatmentsNovember 5, 2024 | msn.comAlphaCentric Advisors LLC Reduces Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)AlphaCentric Advisors LLC decreased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 20.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 97,000 shares of the companyNovember 5, 2024 | marketbeat.comEarnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsNovember 2, 2024 | finance.yahoo.comHarmony Biosciences price target raised to $59 from $56 at OppenheimerNovember 1, 2024 | markets.businessinsider.comWhy Harmony Biosciences (HRMY) Stock Is Down 18% TodayNovember 1, 2024 | benzinga.comUpdate: HRMY, MGPI and OTEX, October 29November 1, 2024 | forbes.comJeffrey Dierks Sells 21,496 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) StockNovember 1, 2024 | insidertrades.comHarmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume Following Analyst UpgradeHarmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume After Analyst UpgradeOctober 31, 2024 | marketbeat.comHRMY FY2024 EPS Estimate Raised by Cantor FitzgeraldHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Cantor Fitzgerald upped their FY2024 earnings estimates for shares of Harmony Biosciences in a research report issued to clients and investors on Wednesday, October 30th. Cantor Fitzgerald analyst C. Duncan now expects that the compOctober 31, 2024 | marketbeat.comHarmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling ShareholdersOctober 30, 2024 | prnewswire.comHarmony Biosciences (NASDAQ:HRMY) Price Target Raised to $58.00 at Cantor FitzgeraldCantor Fitzgerald raised their price objective on Harmony Biosciences from $51.00 to $58.00 and gave the company an "overweight" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comHarmony Biosciences: Strong Q3 and Future GrowthOctober 30, 2024 | markets.businessinsider.comCantor Fitzgerald Sticks to Its Buy Rating for Harmony Biosciences Holdings (HRMY)October 30, 2024 | markets.businessinsider.comHarmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...October 30, 2024 | finance.yahoo.comHarmony Biosciences (NASDAQ:HRMY) Given "Outperform" Rating at OppenheimerOppenheimer restated an "outperform" rating and set a $59.00 price objective (up previously from $56.00) on shares of Harmony Biosciences in a report on Wednesday.October 30, 2024 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Announces Quarterly Earnings Results, Beats Expectations By $0.15 EPSHarmony Biosciences (NASDAQ:HRMY - Get Free Report) issued its earnings results on Tuesday. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.15. Harmony Biosciences had a net margin of 17.53% and a return on equity of 22.97%. The company had revenue of $186.00 million for the quarter, compared to analysts' expectations of $184.07 million. During the same period in the prior year, the business earned $0.63 EPS. The firm's quarterly revenue was up 16.0% on a year-over-year basis.October 30, 2024 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Shares Gap Down - What's Next?Harmony Biosciences (NASDAQ:HRMY) Shares Gap Down - Here's What HappenedOctober 30, 2024 | marketbeat.comHarmony Biosciences Holdings: Strong Financials and Strategic Advancements Reinforce Buy RatingOctober 30, 2024 | markets.businessinsider.com Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼0.840.61▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼125▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lantheus News Nuvalent News Legend Biotech News Blueprint Medicines News Elanco Animal Health News Cytokinetics News TG Therapeutics News Viking Therapeutics News BridgeBio Pharma News Crinetics Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
